DOI: 10.12890/2024_004390
Severe gastrointestinal cytomegalovirus infection in a patient diagnosed with late onset combined immunodeficiency
Authors
aantolig@bellvitgehospital.cat
Keywords
Primary Immunodeficiency, late onset combined immunodeficiency, opportunistic infection, cytomegalovirusAbstract
Late onset combined immunodeficiency (LOCID) is a rare variant of common variable immunodeficiency (CVID), typically affecting adult patients who present with opportunistic infections (OI) and/or low CD4+ T lymphocytes. Diagnostic delay is common due to the rareness of this entity, increasing morbidity and mortality. We report on a 66-year-old male who developed a severe gastrointestinal cytomegalovirus (CMV) infection, refractory to antiviral treatment and anti-cytomegalovirus specific human immunoglobulin administration, with a fatal outcome due to an undiagnosed LOCID.
References
- Thalhammer J, Kindle G, Nieters A, Rusch S, Seppänen MRJ, Fischer A, et al. Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations. J Allergy Clin Immunol 2021;148:1332–1341.
- Malphetters M, Gérard L, Carmagnat M, Mouillot G, Vinve N, Boutboul D, et al. Late-onset combined immune deficiency: a subset of common variable immunodeficiency with severe T cell defect. Clinical Infect Dis 2009;49:1329–1338.
- Hamami A, Rkain M, Benhachem M, Ghannam A, Elouali A, Babakhouya A, et al. Late onset combined immune deficiency (LOCID) revealed by haemolytic anaemia in a child: a case report. Open J Pediatr 2023;13:347–351.
- von Spee-Mayer C, Koemm V, Wehr C, Goldaker S, Kindle G, Bulashevska A, et al. Evaluating laboratory criteria for combined immunodeficiency in adult patients diagnosed with common variable immunodeficiency. Clin Immunol 2019;203:59–62.
- Wetwittayakhlang P, Rujeerapaiboon N, Wetwittayakhlung P, Sripongpun P, Pruphetkaew N, Jandee S, et al. Clinical features, endoscopic findings, and predictive factors for mortality in tissue-invasive gastrointestinal cytomegalovirus disease between immunocompetent and immunocompromised patients. Gastroenterol Res Pract 2021;2021:8886525.
- Izquierdo Rubio S, Taxonera Samsó C, Ladero Quesada JM, Almansa Menchero C, Díaz-Rubio M. Infección diseminada y severa por citomegalovirus en paciente inmunocompetente. An Med Interna (Madrid) 2002;19:234–236.
- Walti CS, Khanna N, Avery RK, Helanterä I. New treatment options for refractory/resistant CMV infection. Transpl Int 2023;36:11785.
- Malagola M, Peccatori J, Greco R, Serio F, Santarone S, Paola lori A, et al. ANTI-CMV immunoglobulins in association with ANTI-CMV drugs in patients with hematological malignancies submitted to allogeneic stem cell transplantation: a multi-center retrospective experience. Blood 2018;132:3381.
- Vargas-Mora P, Morgado-Carrasco D, Fustà-Novell X. Porokeratosis: a review of its pathophysiology, clinical manifestations, diagnosis, and treatment. Actas Dermosifiliogr (engl Ed.) 2020;111:545–560.
- Staels F, Collignon T, Betrains A, Gerbaux M, Willemsen M, Humblet-Baron S, et al. Monogenic adult-onset inborn errors of immunity. Front Immunol 2021;12:753978.